These observations are in line with previous work by our group showing that MDK expression promoted resistance to anticancer agent-induced differentiated glioma cell death via this tyrosine kinase receptor rather than PTPRz or other receptors that have been proposed to mediate MDK actions in other contexts 10. This evidence concerns the gene NTRK1 and central nervous system cancer.